Skip to main content
Top
Published in: Rheumatology International 7/2013

01-07-2013 | Case Report

IgG4-related systemic disease: an uncommon presentation for an uncommon disease

Authors: Karim Richard Masri, Timothy Shaver

Published in: Rheumatology International | Issue 7/2013

Login to get access

Abstract

IgG4-related systemic disease is an emerging disease process that manifests with a constellation of features, most commonly but not exclusive to swelling and tuberous growth in the lacrimal and salivary glands, potentially involving many other organ systems. This condition often prompts investigations into malignancy or needless radical surgical procedures. A 58-year-old male was presented to a rheumatologist after several biopsies were done that were suspicious for neoplasia, involving the lacrimal gland and lung. The diagnosis was confirmed when tissue from the lacrimal gland biopsy was reviewed with special stains for IgG4, performed at the Mayo Clinic. This patient is interesting because his disease included bilateral lacrimal glands—at different intervals, the submandibular glands, the lung, and the thyroid gland. His disease responded to immunosuppression. Literature has shown resolution of the tumors upon starting glucocorticoids or rituximab. Our patient was given a course of prednisone and methotrexate with normal follow-up CT chest and physical exam.
Literature
1.
go back to reference Mikulicz J (1892) Uber eine eigenartige symmetrische erkrankung der thränen- und mundspeicheldrüsen. In: Billroth T (ed) Beiträge zur chirurgie festschrift gewidmet. Ferdinand Enke, Stuttgart, pp 610–630 Mikulicz J (1892) Uber eine eigenartige symmetrische erkrankung der thränen- und mundspeicheldrüsen. In: Billroth T (ed) Beiträge zur chirurgie festschrift gewidmet. Ferdinand Enke, Stuttgart, pp 610–630
2.
go back to reference Mikulicz J (1937–1938) Concerning a peculiar symmetrical disease of the lacrimal and salivary glands. Modern Class 2:165–186 Mikulicz J (1937–1938) Concerning a peculiar symmetrical disease of the lacrimal and salivary glands. Modern Class 2:165–186
3.
4.
go back to reference Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38:982–984PubMedCrossRef Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38:982–984PubMedCrossRef
5.
go back to reference Kitagawa S, Zen Y, Harada K et al (2005) Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner’s tumor). Am J Surg Pathol 29:783–791PubMedCrossRef Kitagawa S, Zen Y, Harada K et al (2005) Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner’s tumor). Am J Surg Pathol 29:783–791PubMedCrossRef
6.
go back to reference Geyer JT, Ferry JA, Harris NL et al (2010) Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol 34:202–210PubMedCrossRef Geyer JT, Ferry JA, Harris NL et al (2010) Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol 34:202–210PubMedCrossRef
7.
go back to reference Yamamoto M, Takahashi H, Ohara M et al (2006) A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol 16:335–340PubMedCrossRef Yamamoto M, Takahashi H, Ohara M et al (2006) A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol 16:335–340PubMedCrossRef
Metadata
Title
IgG4-related systemic disease: an uncommon presentation for an uncommon disease
Authors
Karim Richard Masri
Timothy Shaver
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2677-4

Other articles of this Issue 7/2013

Rheumatology International 7/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.